ZUnclassifiedEIN: 996061997

Willocks Construction Corporation Employees Fringe Benefit Plan

Keaau, Hawaii

CHealth Score
35C

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Below Average

💰
$54K
Total Revenue
📊
$55K
Total Expenses
🏦
$15K
Net Assets
📋
N/A
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+0.0%
Year-over-year change (2023 → 2024)
Net Margin
-2.9%
Revenue minus expenses as % of revenue

Filing History

14 filings on record
YearRevenueExpensesAssets
2024$53,768$55,3234%$15,0659%
2023$53,75648%$53,27655%$16,6203%
2022$102,39652%$118,62845%$16,14050%
2021$214,19735%$217,64147%$32,37210%
2020$158,70512%$147,60515%$35,81645%
2019$179,64626%$173,48019%$24,71633%
2018$142,61719%$145,53217%$18,55014%
2017$119,97825%$124,06326%$21,46516%
2016$159,25440%$167,76497%$25,55025%
2015$113,73832%$85,14917%$34,060523%
2014$86,38857%$102,58750%$5,47175%
2013$199,45427%$207,04921%$21,67026%
2012$157,5855%$171,7364%$29,265
2011$165,627$165,085$0

Frequently Asked Questions

What does Willocks Construction Corporation Employees Fringe Benefit Plan do?

Willocks Construction Corporation Employees Fringe Benefit Plan is a unclassified nonprofit organization based in Hawaii. It is classified under NTEE code Z and is registered as a 501(c) tax-exempt organization with the IRS.

Is Willocks Construction Corporation Employees Fringe Benefit Plan financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Willocks Construction Corporation Employees Fringe Benefit Plan.

How much revenue does Willocks Construction Corporation Employees Fringe Benefit Plan generate?

Willocks Construction Corporation Employees Fringe Benefit Plan reports $52K in annual revenue and holds $8K in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Unclassified category, or browse all nonprofits in Hawaii.